 | • レポートコード：GIR201105951 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、オカリバの世界市場を調査対象にし、オカリバの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（5mg、10mg）、用途別分析（原発性胆汁性肝硬変、非アルコール性脂肪肝疾患、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Intercept Pharmaceuticals、Dainippon Sumitomo Pharma ・メーカー別販売量、売上、市場シェア ・オカリバの地域別市場分析 ・オカリバの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・オカリバのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・オカリバのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・オカリバの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・オカリバの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・オカリバの種類別市場規模2015-2020：5mg、10mg ・オカリバの用途別市場規模2015-2020：原発性胆汁性肝硬変、非アルコール性脂肪肝疾患、その他 ・オカリバの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Ocaliva market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Ocaliva market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Ocaliva market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Ocaliva market has been segmented into
5mg
10mg
By Application, Ocaliva has been segmented into:
Primary Biliary Cirrhosis
Nonalcoholic Fatty Liver Disease
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Ocaliva market presented in the report. This section sheds light on the sales growth of different regional and country-level Ocaliva markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Ocaliva market.
The report offers in-depth assessment of the growth and other aspects of the Ocaliva market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Ocaliva Market Share Analysis
Ocaliva competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Ocaliva sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Ocaliva sales, revenue and market share for each player covered in this report.
The major players covered in Ocaliva are:
Intercept Pharmaceuticals
Dainippon Sumitomo Pharma
Among other players domestic and global, Ocaliva market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ocaliva product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ocaliva, with price, sales, revenue and global market share of Ocaliva in 2018 and 2019.
Chapter 3, the Ocaliva competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ocaliva breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Ocaliva market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Ocaliva sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Ocaliva Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ocaliva Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 5mg
1.2.3 10mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Ocaliva Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Primary Biliary Cirrhosis
1.3.3 Nonalcoholic Fatty Liver Disease
1.3.4 Other
1.4 Overview of Global Ocaliva Market
1.4.1 Global Ocaliva Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Intercept Pharmaceuticals
2.1.1 Intercept Pharmaceuticals Details
2.1.2 Intercept Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Intercept Pharmaceuticals SWOT Analysis
2.1.4 Intercept Pharmaceuticals Product and Services
2.1.5 Intercept Pharmaceuticals Ocaliva Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Dainippon Sumitomo Pharma
2.2.1 Dainippon Sumitomo Pharma Details
2.2.2 Dainippon Sumitomo Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Dainippon Sumitomo Pharma SWOT Analysis
2.2.4 Dainippon Sumitomo Pharma Product and Services
2.2.5 Dainippon Sumitomo Pharma Ocaliva Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Ocaliva Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Ocaliva Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Ocaliva Manufacturer Market Share in 2019
3.3.2 Top 6 Ocaliva Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Ocaliva Sales, Revenue and Market Share by Regions
4.1.1 Global Ocaliva Sales and Market Share by Regions (2015-2020)
4.1.2 Global Ocaliva Revenue and Market Share by Regions (2015-2020)
4.2 North America Ocaliva Sales and Growth Rate (2015-2020)
4.3 Europe Ocaliva Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Ocaliva Sales and Growth Rate (2015-2020)
4.5 South America Ocaliva Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Ocaliva Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Ocaliva Sales, Revenue and Market Share by Country
5.1.1 North America Ocaliva Sales and Market Share by Country (2015-2020)
5.1.2 North America Ocaliva Revenue and Market Share by Country (2015-2020)
5.2 United States Ocaliva Sales and Growth Rate (2015-2020)
5.3 Canada Ocaliva Sales and Growth Rate (2015-2020)
5.4 Mexico Ocaliva Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Ocaliva Sales, Revenue and Market Share by Country
6.1.1 Europe Ocaliva Sales and Market Share by Country (2015-2020)
6.1.2 Europe Ocaliva Revenue and Market Share by Country (2015-2020)
6.2 Germany Ocaliva Sales and Growth Rate (2015-2020)
6.3 UK Ocaliva Sales and Growth Rate (2015-2020)
6.4 France Ocaliva Sales and Growth Rate (2015-2020)
6.5 Russia Ocaliva Sales and Growth Rate (2015-2020)
6.6 Italy Ocaliva Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Ocaliva Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Ocaliva Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Ocaliva Revenue and Market Share by Regions (2015-2020)
7.2 China Ocaliva Sales and Growth Rate (2015-2020)
7.3 Japan Ocaliva Sales and Growth Rate (2015-2020)
7.4 Korea Ocaliva Sales and Growth Rate (2015-2020)
7.5 India Ocaliva Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Ocaliva Sales and Growth Rate (2015-2020)
7.7 Australia Ocaliva Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Ocaliva Sales, Revenue and Market Share by Country
8.1.1 South America Ocaliva Sales and Market Share by Country (2015-2020)
8.1.2 South America Ocaliva Revenue and Market Share by Country (2015-2020)
8.2 Brazil Ocaliva Sales and Growth Rate (2015-2020)
8.3 Argentina Ocaliva Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Ocaliva Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Ocaliva Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Ocaliva Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Ocaliva Sales and Growth Rate (2015-2020)
9.3 Turkey Ocaliva Sales and Growth Rate (2015-2020)
9.4 Egypt Ocaliva Sales and Growth Rate (2015-2020)
9.5 South Africa Ocaliva Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Ocaliva Sales and Market Share by Type (2015-2020)
10.2 Global Ocaliva Revenue and Market Share by Type (2015-2020)
10.3 Global Ocaliva Price by Type (2015-2020)
11 Global Ocaliva Market Segment by Application
11.1 Global Ocaliva Sales Market Share by Application (2015-2020)
11.2 Global Ocaliva Revenue Market Share by Application (2015-2020)
11.3 Global Ocaliva Price by Application (2015-2020)
12 Market Forecast
12.1 Global Ocaliva Sales, Revenue and Growth Rate (2021-2025)
12.2 Ocaliva Market Forecast by Regions (2021-2025)
12.2.1 North America Ocaliva Market Forecast (2021-2025)
12.2.2 Europe Ocaliva Market Forecast (2021-2025)
12.2.3 Asia-Pacific Ocaliva Market Forecast (2021-2025)
12.2.4 South America Ocaliva Market Forecast (2021-2025)
12.2.5 Middle East & Africa Ocaliva Market Forecast (2021-2025)
12.3 Ocaliva Market Forecast by Type (2021-2025)
12.3.1 Global Ocaliva Sales Forecast by Type (2021-2025)
12.3.2 Global Ocaliva Market Share Forecast by Type (2021-2025)
12.4 Ocaliva Market Forecast by Application (2021-2025)
12.4.1 Global Ocaliva Sales Forecast by Application (2021-2025)
12.4.2 Global Ocaliva Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Ocaliva Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Ocaliva by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Ocaliva Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Intercept Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Intercept Pharmaceuticals Ocaliva Major Business
Table 9. Intercept Pharmaceuticals Ocaliva Total Revenue (USD Million) (2017-2018)
Table 10. Intercept Pharmaceuticals SWOT Analysis
Table 11. Intercept Pharmaceuticals Ocaliva Product and Services
Table 12. Intercept Pharmaceuticals Ocaliva Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Dainippon Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Dainippon Sumitomo Pharma Ocaliva Major Business
Table 15. Dainippon Sumitomo Pharma Ocaliva Total Revenue (USD Million) (2017-2018)
Table 16. Dainippon Sumitomo Pharma SWOT Analysis
Table 17. Dainippon Sumitomo Pharma Ocaliva Product and Services
Table 18. Dainippon Sumitomo Pharma Ocaliva Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Global Ocaliva Sales by Manufacturer (2018-2019) (K Units)
Table 20. Global Ocaliva Revenue by Manufacturer (2018-2019) (USD Million)
Table 21. Global Ocaliva Sales by Regions (2015-2020) (K Units)
Table 22. Global Ocaliva Sales Market Share by Regions (2015-2020)
Table 23. Global Ocaliva Revenue by Regions (2015-2020) (USD Million)
Table 24. North America Ocaliva Sales by Countries (2015-2020) (K Units)
Table 25. North America Ocaliva Sales Market Share by Countries (2015-2020)
Table 26. North America Ocaliva Revenue by Countries (2015-2020) (USD Million)
Table 27. North America Ocaliva Revenue Market Share by Countries (2015-2020)
Table 28. Europe Ocaliva Sales by Countries (2015-2020) (K Units)
Table 29. Europe Ocaliva Sales Market Share by Countries (2015-2020)
Table 30. Europe Ocaliva Revenue by Countries (2015-2020) (USD Million)
Table 31. Asia-Pacific Ocaliva Sales by Regions (2015-2020) (K Units)
Table 32. Asia-Pacific Ocaliva Sales Market Share by Regions (2015-2020)
Table 33. Asia-Pacific Ocaliva Revenue by Regions (2015-2020) (USD Million)
Table 34. South America Ocaliva Sales by Countries (2015-2020) (K Units)
Table 35. South America Ocaliva Sales Market Share by Countries (2015-2020)
Table 36. South America Ocaliva Revenue by Countries (2015-2020) (USD Million)
Table 37. South America Ocaliva Revenue Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Ocaliva Sales by Countries (2015-2020) (K Units)
Table 39. Middle East & Africa Ocaliva Sales Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Ocaliva Revenue by Countries (2015-2020) (USD Million)
Table 41. Middle East & Africa Ocaliva Revenue Market Share by Countries (2015-2020)
Table 42. Global Ocaliva Sales by Type (2015-2020) (K Units)
Table 43. Global Ocaliva Sales Share by Type (2015-2020)
Table 44. Global Ocaliva Revenue by Type (2015-2020) (USD Million)
Table 45. Global Ocaliva Revenue Share by Type (2015-2020)
Table 46. Global Ocaliva Sales by Application (2015-2020) (K Units)
Table 47. Global Ocaliva Sales Share by Application (2015-2020)
Table 48. Global Ocaliva Sales Forecast by Regions (2021-2025) (K Units)
Table 49. Global Ocaliva Market Share Forecast by Regions (2021-2025)
Table 50. Global Ocaliva Sales Forecast by Type (2021-2025) (K Units)
Table 51. Global Ocaliva Market Share Forecast by Type (2021-2025)
Table 52. Global Ocaliva Sales Forecast by Application (2021-2025)
Table 53. Global Ocaliva Market Share Forecast by Application (2021-2025)
Table 54. Direct Channel Pros & Cons
Table 55. Indirect Channel Pros & Cons
Table 56. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Ocaliva Picture
Figure 2. Global Sales Market Share of Ocaliva by Type in 2019
Figure 3. 5mg Picture
Figure 4. 10mg Picture
Figure 5. Ocaliva Sales Market Share by Application in 2018
Figure 6. Primary Biliary Cirrhosis Picture
Figure 7. Nonalcoholic Fatty Liver Disease Picture
Figure 8. Other Picture
Figure 9. Global Ocaliva Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Ocaliva Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Ocaliva Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Ocaliva Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Ocaliva Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Ocaliva Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Ocaliva Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Ocaliva Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Ocaliva Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Ocaliva Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Ocaliva Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Ocaliva Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Ocaliva Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Ocaliva Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Ocaliva Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Ocaliva Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Ocaliva Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Ocaliva Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Ocaliva Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Ocaliva Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Ocaliva Sales Market Share by Manufacturer in 2019
Figure 30. Global Ocaliva Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Ocaliva Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Ocaliva Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Ocaliva Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Ocaliva Revenue Market Share by Regions (2015-2020)
Figure 37. Global Ocaliva Revenue Market Share by Regions in 2018
Figure 38. North America Ocaliva Sales and Growth Rate (2015-2020)
Figure 39. Europe Ocaliva Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Ocaliva Sales and Growth Rate (2015-2020)
Figure 41. South America Ocaliva Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Ocaliva Sales and Growth Rate (2015-2020)
Figure 43. North America Ocaliva Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Ocaliva Sales Market Share by Countries (2015-2020)
Figure 45. North America Ocaliva Sales Market Share by Countries in 2018
Figure 46. North America Ocaliva Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Ocaliva Revenue Market Share by Countries in 2018
Figure 48. United States Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Ocaliva Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Ocaliva Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Ocaliva Revenue Market Share by Countries in 2019
Figure 54. Germany Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Ocaliva Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Ocaliva Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Ocaliva Revenue Market Share by Regions 2019
Figure 62. China Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Ocaliva Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Ocaliva Sales Market Share by Countries in 2019
Figure 69. South America Ocaliva Revenue Market Share by Countries in 2019
Figure 70. Brazil Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Ocaliva Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Ocaliva Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Ocaliva Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Ocaliva Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Ocaliva Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Ocaliva Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Ocaliva Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Ocaliva Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Ocaliva Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Ocaliva Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Ocaliva Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Ocaliva Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
原発性胆汁性肝硬変治療薬の世界市場 2020年 Market Overview The global Primary Biliary Cirrhosis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Primary Biliar…- オベチコール酸薬の世界市場 2020年 Market Overview The global Obeticholic Acid Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Obeticholic Acid Drug m…
- 遊離脂肪酸受容体4の世界市場 2020年 Market Overview The global Free Fatty Acid Receptor 4 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Free Fatty Acid Re…
- 脂肪アミンの世界市場 2020年 Market Overview The global Fatty Amines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.9% in the forecast period of 2020 to 2025 and will expected to reach USD 3574.2 million by 2025, from USD 3069.8 million in 2019. The Fatty Amines market rep…
- 肝疾患治療の世界市場 2020年 Market Overview The global Liver Diseases Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Liver Diseases Treat…